Is KTYCF or MRK a better dividend investment in 2026?

KTYCF currently yields 19.05% with a 5% 5-year dividend growth rate. MRK yields 3.25% with 8.2% growth. The better choice depends on your goal: KTYCF offers higher current income.

What is the dividend yield difference between KTYCF and MRK?

KTYCF has a forward dividend yield of 19.05% ($2.00/share annually). MRK yields 3.25% ($3.08/share annually). The yield gap is 15.80 percentage points.

Home › Compare › KTYCF vs MRK

KTYCF vs MRK: Dividend Comparison 2026

KTYCF yields 19.05% · MRK yields 3.25%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 KTYCF wins by $38.1K in total portfolio value

INVESTMENT

TIME HORIZON10 years

KTYCF

● Live price

19.05%

Share price

$10.50

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$68.9K

Annual income

$6,079.53

Full KTYCF calculator →

MRK

Merck & Co. Inc.

● Live price

3.25%

Share price

$94.80

Annual div

$3.08

5Y div CAGR

8.2%

Payout ratio

42%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$950.29

Full MRK calculator →

Portfolio growth — KTYCF vs MRK

📍 KTYCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	KTYCF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, KTYCF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

KTYCF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

KTYCF

Annual income on $10K today (after 15% tax)

$1,619.05/yr

After 10yr DRIP, annual income (after tax)

$5,167.60/yr

MRK

Annual income on $10K today (after 15% tax)

$276.16/yr

After 10yr DRIP, annual income (after tax)

$807.75/yr

At 15% tax rate, KTYCF beats the other by $4,359.85/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of KTYCF + MRK for your $10,000?

KTYCF: 50%MRK: 50%

100% MRK50/50100% KTYCF

Portfolio after 10yr

$49.8K

Annual income

$3,514.92/yr

Blended yield

7.06%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

KTYCF

No analyst data

Altman Z

7.6

Piotroski

7/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+35.6% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

KTYCF buys

MRK buys

No recent congressional trades found for KTYCF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricKTYCFMRK

Forward yield	19.05% ✓	3.25%
Annual dividend / share	$2.00	$3.08 ✓
Payout ratio	50%	42% ✓
1-year div growth	0%	5.5% ✓
5-year div CAGR	0%	8.2% ✓
Portfolio after 10y	$68.9K ✓	$30.7K
Annual income after 10y	$6,079.53 ✓	$950.29
Total dividends collected	$38.2K ✓	$6.1K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: KTYCF vs MRK ($10,000, DRIP)

Year	KTYCF Portfolio	KTYCF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$12,605	$1,904.76	$11,192	$351.54	+$1.4K → KTYCF
2	$15,731	$2,243.84	$12,524	$392.70	+$3.2K → KTYCF
3	$19,449	$2,617.14	$14,015	$438.65	+$5.4K → KTYCF
4	$23,835	$3,024.07	$15,682	$489.96	+$8.2K → KTYCF
5	$28,967	$3,463.51	$17,547	$547.23	+$11.4K → KTYCF
6	$34,928	$3,933.88	$19,632	$611.16	+$15.3K → KTYCF
7	$41,806	$4,433.18	$21,963	$682.53	+$19.8K → KTYCF
8	$49,692	$4,959.03	$24,571	$762.18	+$25.1K → KTYCF
9	$58,679	$5,508.79	$27,486	$851.08	+$31.2K → KTYCF
10	$68,866	$6,079.53	$30,745	$950.29	+$38.1K → KTYCF

KTYCF vs MRK: Complete Analysis 2026

KTYCF — Stock

Kits Eyecare Ltd. operates a digital eyecare platform for eyes in the United States and Canada. The company manufactures progressive and contact lenses, eyeglasses, and frames under the KITS brand, as well as distributes eyewear products of various brands. It operates through a network of optical e-commerce websites, including KITS.com, KITS.ca, OptiContacts.com, and ContactsExpress.ca. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.

Full KTYCF Calculator →

MRK — Healthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →

📬

Get this KTYCF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

KTYCF vs SCHD KTYCF vs JEPI KTYCF vs O KTYCF vs KO KTYCF vs MAIN KTYCF vs JNJ KTYCF vs ABBV KTYCF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.